THE EFFECT OF MITOMYCIN-C ON SUPERFICIAL BLADDER-CANCER

被引:62
|
作者
SOLOWAY, MS
MURPHY, WM
DEFURIA, MD
CROOKE, S
FINEBAUM, P
机构
[1] BAPTIST MEM HOSP,DEPT PATHOL,MEMPHIS,TN 38146
[2] BRISTOL MYERS CO LABS,DEPT CLIN RES,SYRACUSE,NY 13201
来源
JOURNAL OF UROLOGY | 1981年 / 125卷 / 05期
关键词
D O I
10.1016/S0022-5347(17)55149-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:646 / 648
页数:3
相关论文
共 50 条
  • [21] EFFECT OF INTRAVESICAL MITOMYCIN-C ON RECURRENCE OF NEWLY DIAGNOSED SUPERFICIAL BLADDER-CANCER - INTERIM-REPORT FROM THE MEDICAL-RESEARCH COUNCIL SUBGROUP ON SUPERFICIAL BLADDER-CANCER (UROLOGICAL CANCER WORKING PARTY)
    TOLLEY, DA
    HARGREAVE, TB
    SMITH, PH
    WILLIAMS, JL
    GRIGOR, KM
    PARMAR, MKB
    FREEDMAN, LS
    USCINSKA, BM
    BRITISH MEDICAL JOURNAL, 1988, 296 (6639): : 1759 - 1761
  • [22] MITOMYCIN-C IN SUPERFICIAL BLADDER-CANCER - IS LONG-TERM MAINTENANCE THERAPY WORTHWHILE AFTER INITIAL TREATMENT
    HAMDY, FC
    HASTIE, KJ
    KERRY, R
    WILLIAMS, JL
    BRITISH JOURNAL OF UROLOGY, 1993, 71 (02): : 183 - 186
  • [23] INVITRO STUDY OF THE INTERACTION OF DOXORUBICIN, THIOTEPA, AND MITOMYCIN-C, AGENTS USED FOR INTRAVESICAL CHEMOTHERAPY OF SUPERFICIAL BLADDER-CANCER
    SERAPHIM, LA
    PERRAPATO, SD
    SLOCUM, HK
    RUSTUM, YM
    HUBEN, RP
    JOURNAL OF UROLOGY, 1991, 145 (03): : 613 - 617
  • [24] SUBSEQUENT TUMOR-ANALYSIS OF 36 PATIENTS WHO HAVE RECEIVED INTRAVESICAL MITOMYCIN-C FOR SUPERFICIAL BLADDER-CANCER
    SOLOWAY, MS
    FORD, KS
    JOURNAL OF UROLOGY, 1983, 130 (01): : 74 - 78
  • [25] INTRAVESICAL LONG-TERM CHEMOPROPHYLAXIS WITH MITOMYCIN-C FOR SUPERFICIAL BLADDER-CANCER - RECURRENCE AND PROGRESSION AFTER 3 YEARS
    RASSWEILER, J
    HATH, U
    BUB, P
    EISENBERGER, F
    AKTUELLE UROLOGIE, 1988, 19 (03) : 139 - 144
  • [26] TREATMENT SCHEDULE OF INTRAVESICAL CHEMOTHERAPY WITH MITOMYCIN-C IN SUPERFICIAL BLADDER-CANCER - SHORT-TERM COURSES OR MAINTENANCE THERAPY
    VANDERMEIJDEN, APM
    DEBRUYNE, FMJ
    UROLOGY, 1988, 31 (03) : 26 - 29
  • [27] TREATMENT OF SUPERFICIAL BLADDER-CANCER WITH INTRAVESICAL MITOMYCIN-C - ANALYSIS OF IMMEDIATE AND LONG-TERM RESPONSE IN 70 PATIENTS
    SOLOWAY, MS
    JOURNAL OF UROLOGY, 1985, 134 (06): : 1107 - 1109
  • [28] MITOMYCIN-C INTRAVESICAL THERAPY IN NONINVASIVE BLADDER-CANCER AFTER FAILURE ON THIOTEPA
    ISSELL, BF
    PROUT, GR
    SOLOWAY, MS
    CUMMINGS, KB
    BRANNEN, G
    VEENEMA, R
    FLANAGAN, M
    BLOCK, NL
    SUMMERS, JL
    LEVIN, EA
    DEFURIA, MD
    CANCER, 1984, 53 (05) : 1025 - 1028
  • [29] PROGNOSTIC-SIGNIFICANCE OF URINE CYTOLOGY ON INITIAL FOLLOW-UP AFTER INTRAVESICAL MITOMYCIN-C FOR SUPERFICIAL BLADDER-CANCER
    CANT, JD
    MURPHY, WM
    SOLOWAY, MS
    CANCER, 1986, 57 (11) : 2119 - 2122
  • [30] USE OF PHARMACOLOGICAL DATA AND COMPUTER-SIMULATIONS TO DESIGN AN EFFICACY TRIAL OF INTRAVESICAL MITOMYCIN-C THERAPY FOR SUPERFICIAL BLADDER-CANCER
    WIENTJES, MG
    BADALAMENT, RA
    AU, JLS
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 32 (04) : 255 - 262